Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 22, 2025 • 5:00 PM ET

Date/Time Source News Release
02/23/2023 09:55 AM EST ACCESSWIRE North Star Leasing and Avail Scientific Have Arranged a $25 Million Dollar Lease Finance Facility
02/15/2023 11:20 AM EST ACCESSWIRE "Avail Scientific Expecting Exponential Annual Growth of $6 million within Florida Rehab Clinics!" says Gerard Maynard, Chief Revenue Officer for Avail Scientific
02/02/2023 06:50 AM EST ACCESSWIRE Relai Neuro Selected as Official Vendor to Florida Justice Administrative Commission (JAC)
01/31/2023 07:00 AM EST ACCESSWIRE Avail Scientific Appoints Gerard Maynard as Chief Revenue Officer
01/26/2023 10:00 AM EST ACCESSWIRE Relai Neuro CEO Appointed as Interim CEO to Avail Scientific
01/19/2023 07:00 AM EST ACCESSWIRE Avail Scientific Signs LOI to Acquire Florida Neurological Testing Company Relai Neuro
01/06/2023 08:00 AM EST ACCESSWIRE Mobile Lads/Avail Scientific to Enter the Neurological Testing and Data Management Area with A Continued Emphasis on Monitoring the Effectiveness of Psychedelic Medicines in Mental Health Treatment Via Software and Hardware Systems
03/15/2022 07:00 AM EDT ACCESSWIRE AVAIL SCIENTIFIC INC., Announces the Appointment of Head of Special Operations
02/24/2022 07:00 AM EST ACCESSWIRE MOBILE LADS CORP., Announces a Change of Business Direction to Psychedelics
05/24/2016 08:11 AM EDT Business Wire Mobile Lads Adds Push to Talk (PTT) Appplication to Its Mobile Product Suite
Page
  • 1
  • 2

Additional News

As of June 22, 2025 • 5:00 PM ET

Date/Time Source News Release
There are no press releases available at this time.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.